Analysts: more sales AmerisourceBergen

Over the current book year the total revenue will be 167,91 billion USD (consensus estimates). This is slightly more than 2017's revenue of 153,14 billion USD.

Historical revenues and results AmerisourceBergen plus estimates 2018

equity research

The analysts expect for 2018 a net profit of 1,43 billion USD. For this year the consensus of the result per share is a profit of 6,48 USD. With this the price/earnings-ratio is 12,63.

Analysts expect a dividend of 1,52 USD per share. Thus the dividend yield equals 1,86 percent. The average dividend yield of the pharmaceutical companies is a limited 0,5 percent.

Based on the current number of outstanding shares AmerisourceBergen 's market capitalization 18,01 billion USD.

On Tuesday, the stock closed at 81,83 USD.

Historical stock prices AmerisourceBergen

equity research amerisourcebergen

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.